Effects of Mavacamten Concomitant With Beta-Blockers on Patients With Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials

Am J Ther. 2024 Jul-Aug;31(4):e491-e494. doi: 10.1097/MJT.0000000000001698. Epub 2024 Mar 12.

Authors

Syeda Tayyaba Rehan¹, Abraish Ali¹, Laiba Imran¹, Jawad Ahmed¹, Irfan Ullah², Abdelrahman Sherif Abdalla³, Muhammad Majid³, Muhammad Sohaib Asghar³

Affiliations

¹ Dow University of Health Sciences, Karachi, Pakistan.
² Kabir Medical College, Gandhara University, Peshawar, Pakistan.
³ AdventHealth Sebring, Sebring, FL.

PMID: 38563758
DOI: 10.1097/MJT.0000000000001698

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Adrenergic beta-Antagonists* / therapeutic use
Benzylamines
Cardiomyopathy, Hypertrophic* / drug therapy
Drug Therapy, Combination*
Humans
Randomized Controlled Trials as Topic*
Treatment Outcome
Uracil / analogs & derivatives

Substances

Adrenergic beta-Antagonists
Benzylamines
MYK-461
Uracil